Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Personalized Precision Immunotherapy for Amyotrophic Lateral Sclerosis (ALS).
Crit Rev Immunol. 2023;43(2):1-11. doi: 10.1615/CritRevImmunol.2023048372.
Crit Rev Immunol. 2023.
PMID: 37938192
Review.
Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV- Unmutated Chronic Lymphocytic Leukemia.
Maharaj D, Srinivasan G, Abreu MM, Ko MW, Jewett A, Gouvea J.
Maharaj D, et al. Among authors: gouvea j.
Cells. 2020 Dec 22;10(1):10. doi: 10.3390/cells10010010.
Cells. 2020.
PMID: 33375215
Free PMC article.
Item in Clipboard
Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Maharaj D, Srinivasan G, Makepeace S, Hickey CJ, Gouvea J.
Maharaj D, et al. Among authors: gouvea j.
J Pers Med. 2021 Apr 24;11(5):342. doi: 10.3390/jpm11050342.
J Pers Med. 2021.
PMID: 33923265
Free PMC article.
Item in Clipboard
Young donor white blood cell immunotherapy induces extensive tumor necrosis in advanced-stage solid tumors.
Maharaj D, Vianna PG, Ward W, Messina AJ, Rayborn T, Gouvea JV, Hammer RD, Cui Z.
Maharaj D, et al. Among authors: gouvea jv.
Heliyon. 2017 Oct 31;3(10):e00438. doi: 10.1016/j.heliyon.2017.e00438. eCollection 2017 Oct.
Heliyon. 2017.
PMID: 29159318
Free PMC article.
Item in Clipboard
Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant.
Maharaj D, Vianna P, DeCarvalho G, Pourkalbassi D, Hickey C, Gouvea J.
Maharaj D, et al. Among authors: gouvea j.
Future Sci OA. 2019 Apr 12;5(5):FSO380. doi: 10.2144/fsoa-2019-0009. eCollection 2019 Jun.
Future Sci OA. 2019.
PMID: 31245042
Free PMC article.
Item in Clipboard
Cite
Cite